Business growth

Sberbank created the Immunotechnology company. It was registered on May 15, 100% owned by Sberbank. The activities of Immunotechnologies are aimed at the wholesale of medicines, production of pharmaceutical substances and drugs, as well as scientific research. The new Sberbank company will scale up production of coronavirus vaccine.